Hugo Albrecht

1.8k total citations
50 papers, 1.3k citations indexed

About

Hugo Albrecht is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Hugo Albrecht has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Biomaterials. Recurrent topics in Hugo Albrecht's work include Nanoparticle-Based Drug Delivery (8 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Protein Degradation and Inhibitors (7 papers). Hugo Albrecht is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Protein Degradation and Inhibitors (7 papers). Hugo Albrecht collaborates with scholars based in Australia, Switzerland and United States. Hugo Albrecht's co-authors include Shudong Wang, Robert Milne, C. Victor Jongeneel, Denis Monard, Ulrich Hengst, Mingfeng Yu, Daniel Heß, Sunita K. C. Basnet, J Tschopp and Sarah Diab and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Hugo Albrecht

47 papers receiving 1.3k citations

Peers

Hugo Albrecht
Jiyuan Ke United States
Hugo Albrecht
Citations per year, relative to Hugo Albrecht Hugo Albrecht (= 1×) peers Jiyuan Ke

Countries citing papers authored by Hugo Albrecht

Since Specialization
Citations

This map shows the geographic impact of Hugo Albrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo Albrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo Albrecht more than expected).

Fields of papers citing papers by Hugo Albrecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugo Albrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo Albrecht. The network helps show where Hugo Albrecht may publish in the future.

Co-authorship network of co-authors of Hugo Albrecht

This figure shows the co-authorship network connecting the top 25 collaborators of Hugo Albrecht. A scholar is included among the top collaborators of Hugo Albrecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo Albrecht. Hugo Albrecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Clulow, Andrew J., et al.. (2025). Influence of pendant pyridyl regioisomers on the pH-responsive behaviour of polymer-homopeptide copolymers and micelles. European Polymer Journal. 234. 113931–113931.
3.
Albrecht, Hugo, et al.. (2024). Emerging Applications of Nanoparticles in the Diagnosis and Treatment of Breast Cancer. Journal of Personalized Medicine. 14(7). 723–723. 26 indexed citations
4.
Hussain, Md. Saddam, Andrew J. Clulow, Raja Ganesan, et al.. (2024). Teaching an Old Dog New Tricks: A Global Approach to Enhancing the Cytotoxicity of Drug-Loaded, Non-responsive Micelles Using Oligoelectrolytes. ACS Applied Materials & Interfaces. 16(8). 9736–9748. 4 indexed citations
5.
Clulow, Andrew J., et al.. (2024). Position Matters: Pyridine Regioisomers Influence Secondary Structure and Micelle Morphology in Polymer-Homopolypeptide Micelles. Biomacromolecules. 25(7). 4095–4109. 4 indexed citations
7.
Anshabo, Abel Tesfaye, Sarah Diab, Long Yi, et al.. (2022). An Orally Bioavailable and Highly Efficacious Inhibitor of CDK9/FLT3 for the Treatment of Acute Myeloid Leukemia. Cancers. 14(5). 1113–1113. 10 indexed citations
8.
Teo, Theodosia, et al.. (2022). An overview of CDK3 in cancer: clinical significance and pharmacological implications. Pharmacological Research. 180. 106249–106249. 10 indexed citations
9.
Anshabo, Abel Tesfaye, Robert Milne, Shudong Wang, & Hugo Albrecht. (2021). CDK9: A Comprehensive Review of Its Biology, and Its Role as a Potential Target for Anti-Cancer Agents. Frontiers in Oncology. 11. 678559–678559. 85 indexed citations
10.
Tadesse, Solomon, Malika Kumarasiri, Sunita K. C. Basnet, et al.. (2019). Discovery of CDK5 Inhibitors through Structure-Guided Approach. ACS Medicinal Chemistry Letters. 10(5). 786–791. 21 indexed citations
11.
Yu, Mingfeng, Sunita K. C. Basnet, Malika Kumarasiri, et al.. (2015). Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure–activity relationship analysis and biological evaluation. European Journal of Medicinal Chemistry. 95. 116–126. 31 indexed citations
12.
Teo, Theodosia, Yuchao Yang, Mingfeng Yu, et al.. (2015). An integrated approach for discovery of highly potent and selective Mnk inhibitors: Screening, synthesis and SAR analysis. European Journal of Medicinal Chemistry. 103. 539–550. 23 indexed citations
13.
Basnet, Sunita K. C., Sarah Diab, Raffaella M. Schmid, et al.. (2015). Identification of a Highly Conserved Allosteric Binding Site on Mnk1 and Mnk2. Molecular Pharmacology. 88(5). 935–948. 14 indexed citations
14.
Diab, Sarah, Theodosia Teo, Malika Kumarasiri, et al.. (2014). Discovery of 5‐(2‐(Phenylamino)pyrimidin‐4‐yl)thiazol‐2(3H)‐one Derivatives as Potent Mnk2 Inhibitors: Synthesis, SAR Analysis and Biological Evaluation. ChemMedChem. 9(5). 962–972. 71 indexed citations
15.
Scarsi, Marco, Michael Podvinec, Adrian Roth, et al.. (2006). Sulfonylureas and Glinides Exhibit Peroxisome Proliferator-Activated Receptor γ Activity: A Combined Virtual Screening and Biological Assay Approach. Molecular Pharmacology. 71(2). 398–406. 42 indexed citations
16.
Albrecht, Hugo, Peter Zbinden, Andrea Rizzi, et al.. (2004). High Throughput Screening of β-Amyloid Secretion Inhibitors Using Homogenous Time-Resolved Fluorescence. Combinatorial Chemistry & High Throughput Screening. 7(8). 745–756. 2 indexed citations
17.
Kvajo, Mirna, Hugo Albrecht, Marita Meins, et al.. (2004). Regulation of Brain Proteolytic Activity Is Necessary for theIn VivoFunction of NMDA Receptors. Journal of Neuroscience. 24(43). 9734–9743. 40 indexed citations
18.
Hengst, Ulrich, Hugo Albrecht, Daniel Heß, & Denis Monard. (2001). The Phosphatidylethanolamine-binding Protein Is the Prototype of a Novel Family of Serine Protease Inhibitors. Journal of Biological Chemistry. 276(1). 535–540. 158 indexed citations
19.
Carrel, S, et al.. (1995). Expression of type a and b tumor necrosis factor (TNF) receptors on melanoma cells can be regulated by dbc‐AMP and IFN‐γ. International Journal of Cancer. 62(1). 76–83. 15 indexed citations
20.
Babst, Markus, et al.. (1991). Single amino acid substitutions in the B870 α and β light‐harvesting polypeptides of Rhodobacter capsulatus. European Journal of Biochemistry. 202(2). 277–284. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026